SCHEMBL7780596

SCHEMBL7780596

N#Cc1[nH]nc(-c2ccc(S(N)(=O)=O)cc2)c1-c1ccc(Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
PTGS2 P35354 9/20 0.47
PTGS1 P23219 5/20 0.47
TTK P33981 1/20 0.47
CA12 O43570 6/20 0.46
CA1 P00915 6/20 0.46
CA2 P00918 6/20 0.46
CA9 Q16790 6/20 0.46
CA3 P07451 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
CA5A P35218 1/20 0.46
CA7 P43166 1/20 0.46
CA13 Q8N1Q1 1/20 0.46
CA14 Q9ULX7 1/20 0.46
CA5B Q9Y2D0 1/20 0.46
LDHA P00338 1/20 0.43
LDHB P07195 1/20 0.43
MAP2K7 O14733 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7778056 0.87 PTGS2 (0.51) PTGS2PTGS1MAPK11MAPK14
SCHEMBL8759016 0.81 MAOA (0.45) MAOAMAOBPTGS2PTGS1TTK
SCHEMBL8632292 0.81 PTGS2 (0.41) PTGS2PTGS1CA12CA1CA2
SCHEMBL7780738 0.80 LRRK2 (0.60) PTGS2PTGS1TTKCA12CA1
SCHEMBL7779803 0.80 PTGS2 (0.50) MAOAMAOBPTGS2PTGS1TTK
SCHEMBL7778142 0.80 PTGS2 (0.48) MAOAMAOBPTGS2PTGS1TTK
SCHEMBL7772912 0.77 CA1 (0.52) MAOAMAOBPTGS2PTGS1TTK
SCHEMBL7779654 0.77 LRRK2 (0.60) MAOAMAOBPTGS2PTGS1TTK
SCHEMBL7772883 0.77 PTGS2 (0.47) MAOAMAOBPTGS2PTGS1TTK
SCHEMBL7773067 0.77 PTGS2 (0.47) MAOAMAOBPTGS2PTGS1TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed